Low accuracy of chromogranin A for diagnosing early-stage pancreatic neuroendocrine tumors

The aim of the present study was to evaluate the clinical utility of plasma chromogranin A (CgA) in patients diagnosed with early-stage pancreatic neuroendocrine tumors (PNETs) in terms of diagnostic value and treatment response. A total of 35 patients with PNETs were prospectively enrolled from Aug...

Descripción completa

Detalles Bibliográficos
Autores principales: Tseng, Chao-Ming, Cheng, Tsu-Yao, Chen, Tai-Been, Tien, Yu-Wen, Chen, Chien-Chuan, Lin, Jaw-Town, Wang, Hsiu-Po
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5958764/
https://www.ncbi.nlm.nih.gov/pubmed/29805630
http://dx.doi.org/10.3892/ol.2018.8472

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5958764/
https://www.ncbi.nlm.nih.gov/pubmed/29805630
http://dx.doi.org/10.3892/ol.2018.8472

Ejemplares similares